MTD
Mettler-Toledo International Inc.NYSEHealthcare$1259.94-1.11%ClosedMarket Cap: $25.61B
As of 2026-04-06
Valuation
P/E (TTM)
29.46
PEG
42.01
P/B
-1086.40
P/S
6.36
EV/EBITDA
22.47
DCF Value
$600.54
FCF Yield
3.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
57.5%
Operating Margin
27.8%
Net Margin
21.6%
ROE
-487.2%
ROA
32.3%
ROIC
35.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $1.13B | 58.0% | $343.3M | $285.8M | $14.02 | — |
| FY 2025 | $4.03B | 57.5% | $1.12B | $869.2M | $42.17 | — |
| Q3 2025 | $1.03B | 57.2% | $289.9M | $217.5M | $10.57 | — |
| Q2 2025 | $983.2M | 57.2% | $265.7M | $202.3M | $9.77 | — |
| Q1 2025 | $883.7M | 57.6% | $219.5M | $163.6M | $7.84 | — |
| Q4 2024 | $1.05B | 59.4% | $333.7M | $252.3M | $11.96 | — |
| FY 2024 | $3.87B | 58.2% | $1.13B | $863.1M | $40.67 | — |
| Q3 2024 | $954.5M | 58.1% | $278.3M | $211.5M | $9.94 | — |
| Q2 2024 | $946.8M | 57.8% | $265.9M | $221.8M | $10.37 | — |
| Q1 2024 | $925.9M | 57.2% | $249.1M | $177.5M | $8.24 | — |
| Q4 2023 | $935.0M | 57.1% | $263.7M | $184.8M | $8.52 | — |
| FY 2023 | $3.79B | 57.3% | $1.08B | $788.8M | $35.90 | — |